AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN) have a lot in common. They are both leading drugmakers and have strong dividend ...

The silver lining to the sell-off in dividend stocks is that they're now an even more attractive investment for ...

Palantir delivered an encouraging financial performance in the third quarter. Its customer count increased 39% to 629, and ...

Recent product expansions, including GenAI solutions and IRN 2.0, enhance FactSet's market position and growth trajectory.

The S&P 500 (SNPINDEX: ^GSPC) is up 24% this year, which is more than double its average annual return going back to when it ...